RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Historical cohort study of in utero exposure to uterotonic drugs and cognitive function in young adult life (Reprinted from BMJ, vol 318, pg 433-4, 1999)
Sorensen, HT., Steffensen, FH., Sabroe, S., Rothman, K., Gillman, MW., & Fischer, P. (1999). Historical cohort study of in utero exposure to uterotonic drugs and cognitive function in young adult life (Reprinted from BMJ, vol 318, pg 433-4, 1999). Western Journal of Medicine, 170(5), 260-262.
Objective To examine whether in utero exposure to uterotonic drugs effects cognitive performance in draft-age men. Design Historical cohort study based on birth registry data and cognitive function measured during evaluations fur military service. Subjects 4300 Danish conscripts born between 1973 and 1975, Main outcome measures Mean score in the Boerge Prien test of cognitive function: score is the number of correct answers to 78 questions and correlates with the full scale intelligence quotient. Results The mean Boerge Prien score was similar for those exposed (n = 1011) to uterotonic drugs and those net exposed (n = 3289), 43.1 versus 42.3 after adjustment for confounders. Conclusion Our data indicate that exposure to uterotonic drugs does not affect cognitive function 20 years later
